The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Biora Inc. | COM | 74319F305 | 6,523,751 | 1,694,481 | SH | SOLE | 1,694,481 | 0 | 0 | |||
| Paratek Pharmaceuticals Inc. | NOTE 4.750% 5/0 | 699374AB0 | 8,848,843 | 9,000,000 | PRN | SOLE | 0 | 0 | 9,000,000 | |||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 6,326,162 | 1,792,114 | SH | SOLE | 1,792,114 | 0 | 0 | |||
| RVL PHARMACEUTICALS PLC | SHS | G6S41R101 | 8,177,709 | 14,600,444 | SH | SOLE | 14,600,444 | 0 | 0 | |||
| Omeros Corp | NOTE 6.250%11/1 | 682143AE2 | 11,037,382 | 11,005,000 | PRN | SOLE | 0 | 0 | 11,005,000 | |||
| Biora Inc. | Note 7.250% 12/0 | 74319FAB3 | 60,477,148 | 103,500,000 | PRN | SOLE | 0 | 0 | 103,500,000 | |||
| Omeros Corp | NOTE 5.250% 2/1 | 682143AG7 | 52,755,389 | 71,979,000 | PRN | SOLE | 0 | 0 | 71,979,000 | |||